Multi-Dose Study
13 patient study (seven treated; six control) conducted at the Profil Institute in Germany
Evaluated safety, effect and tolerability of oral insulin tablets when administered 4Xs daily (10 minutes before meals and at bedtime) over 2 weeks
EMISPHERE™ oral insulin tablets positively impacted glycemic control in early-stage Type 2 diabetics
- Key parameters evaluated: serum fructosamine, oral glucose tolerance, insulin sensitivity and secretion